Protein phosphatase 1 regulators in DNA damage signaling

Cell Cycle

Volumn 10, Issue 9, 2011, Pages 1356-1362

  Küntziger, Thomas ^a   Landsverk, Helga B ^b   Collas, Philippe ^a   Syljuåsen, Randi G ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

DNA damage response; DNA repair; PNUTS; PP1

Indexed keywords

APOPTOSIS STIMULATING PROTEIN OF P53; ATM PROTEIN; ATR PROTEIN; AURORA A KINASE; BINDING PROTEIN; BRCA1 PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; COREPRESSOR PROTEIN; CYCLIN DEPENDENT KINASE 1; DNA PROTEIN KINASE; HISTONE H2AX; HISTONE H3; KRUPPEL ASSOCIATED BOX ASSOCIATED PROTEIN 1; NUCLEIC ACID BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 INHIBITOR 2; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; POLO LIKE KINASE 1; PROTEIN CDC25C; PROTEIN KINASE; PROTEIN PP1 NUCLEAR TARGETING SUBUNIT; PROTEIN REPO MAN; REGULATOR PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CELL CYCLE ARREST; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; XENOPUS LAEVIS;

EID: 79955634092     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.9.15442     Document Type: Review

References (115)

1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8.
2. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179-204.
3. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-45. (Pubitemid 46386406)
4. Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455:119-23.
5. 2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004;15:799-811.
6. Syljuasen RG. Checkpoint adaptation in human cells. Oncogene 2007; 26:5833-9.
7. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, III, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6. (Pubitemid 46877472)
8. Bennetzen MV, Larsen DH, Bunkenborg J, Bartek J, Lukas J, Andersen JS. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 2010; 9:1314-23.
9. Bensimon A, Schmidt A, Ziv Y, Elkon R, Wang SY, Chen DJ, et al. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci Signal 2010; 3:3.
10. den Elzen NR, O'Connell MJ. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J 2004; 23:908-18. (Pubitemid 38418757)
11. Hamilton J, Grawenda AM, Bernhard EJ. Phosphatase inhibition and cell survival after DNA damage induced by radiation. Cancer Biol Ther 2009; 8:1577-86.
12. Landsverk HB, Mora-Bermudez F, Landsverk OJ, Hasvold G, Naderi S, Bakke O, et al. The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response. EMBO Rep 2010; 11:868-75.
13. Peng A, Lewellyn AL, Schiemann WP, Maller JL. Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation. Curr Biol 2010; 20:387-96.
14. Tang X, Hui ZG, Cui XL, Garg R, Kastan MB, Xu B. A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage. Mol Cell Biol 2008; 28:2559-66. (Pubitemid 351542357)
15. Trinkle-Mulcahy L, Lamond AI. Mitotic phosphatases: no longer silent partners. Curr Opin Cell Biol 2006; 18:623-31. (Pubitemid 44692470)
16. Bollen M, Gerlich DW, Lesage B. Mitotic phosphatases: from entry guards to exit guides. Trends Cell Biol 2009; 19:531-41.
17. Moorhead GB, Trinkle-Mulcahy L, Ulke-Lemee A. Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol 2007; 8:234-44.
18. Virshup DM, Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 2009; 33:537-45.
19. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298:1912-34. (Pubitemid 35425239)
20. Bollen M. Combinatorial control of protein phosphatase- 1. Trends Biochem Sci 2001; 26:426-31.
21. Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P, Barford D. Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J 1997; 16:1876-87. (Pubitemid 27170949)
22. Hendrickx A, Beullens M, Ceulemans H, Den AT, Van EA, Nicolaescu E, et al. Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem Biol 2009; 16:365-71.
23. Trinkle-Mulcahy L, Andersen J, Lam YW, Moorhead G, Mann M, Lamond AI. Repo-Man recruits PP1 gamma to chromatin and is essential for cell viability. J Cell Biol 2006; 172:679-92.
24. Vagnarelli P, Hudson DF, Ribeiro SA, Trinkle- Mulcahy L, Spence JM, Lai F, et al. Condensin and Repo-Man-PP1 co-operate in the regulation of chromosome architecture during mitosis. Nat Cell Biol 2006; 8:1133-42. (Pubitemid 44473609)
25. Allen PB, Kwon YG, Nairn AC, Greengard P. Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit. J Biol Chem 1998; 273:4089-95. (Pubitemid 28103276)
26. Kim YM, Watanabe T, Allen PB, Lee SJ, Greengard P, Nairn AC, et al. PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit. Characterization of its PP1- and RNA-binding domains and regulation by phosphorylation. J Biol Chem 2003; 278:13819-28. (Pubitemid 36799920)
27. Kreivi JP, Trinkle-Mulcahy L, Lyon CE, Morrice NA, Cohen P, Lamond AI. Purification and characterisation of p99, a nuclear modulator of protein phosphatase 1 activity. FEBS Lett 1997; 420:57-62. (Pubitemid 28037200)
28. Lee SJ, Lim CJ, Min JK, Lee JK, Kim YM, Lee JY, et al. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2. Cell Death Differ 2007; 14:1106-16.
29. Kim H, Lee OH, Xin H, Chen LY, Qin J, Chae HK, et al. TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat Struct Mol Biol 2009; 16:372-9.
30. Landsverk HB, Kirkhus M, Bollen M, Kuntziger T, Collas P. PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner. Biochem J 2005; 390:709-17. (Pubitemid 41395354)
31. Canettieri G, Morantte I, Guzman E, Asahara H, Herzig S, Anderson SD, et al. Attenuation of a phosphorylation-dependent activator by an HDACPP1 complex. Nat Struct Biol 2003; 10:175-81. (Pubitemid 36297986)
32. Lee SJ, Lee JK, Maeng YS, Kim YM, Kwon YG. Langerhans cell protein 1 (LCP1) binds to PNUTS in the nucleus: implications for this complex in transcriptional regulation. Exp Mol Med 2009; 41:189-200.
33. Lee JH, You J, Dobrota E, Skalnik DG. Identification and characterization of a novel human PP1 phosphatase complex. J Biol Chem 2010; 285:24466-76.
34. Rose M, Dutting E, Schroder N, Sticht H, Brandstatter JH, Enz R. PNUTS forms a trimeric protein complex with GABA(C) receptors and protein phosphatase 1. Mol Cell Neurosci 2008; 37:808-19.
35. Palm W, de LT. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42:301-34.
36. Puch CB, Barbier E, Kraut A, Coute Y, Fuchs J, Buhot A, et al. TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs. Arch Biochem Biophys 2010.
37. Zlatanova J, Yaneva J, Leuba SH. Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin. FASEB J 1998; 12:791-9. (Pubitemid 28294669)
38. Kim JS, Krasieva TB, Kurumizaka H, Chen DJ, Taylor AM, Yokomori K. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol 2005; 170:341-7. (Pubitemid 41126934)
39. Mari PO, Florea BI, Persengiev SP, Verkaik NS, Bruggenwirth HT, Modesti M, et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA 2006; 103:18597-602. (Pubitemid 44913456)
40. Huang FL, Glinsmann WH. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur J Biochem 1976; 70:419-26.
41. Wang W, Stukenberg PT, Brautigan DL. Phosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells. Mol Biol Cell 2008; 19:4852-62.
42. Guo CY, Brautigan DL, Larner JM. Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation. J Biol Chem 2002; 277:41756-61. (Pubitemid 35257484)
43. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, et al. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 2007; 282:36177-89.
44. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, et al. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 1996; 10:2067-78. (Pubitemid 26346114)
45. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008; 31:167-77. (Pubitemid 352001394)
46. Noon AT, Shibata A, Rief N, Lobrich M, Stewart GS, Jeggo PA, et al. 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat Cell Biol 2010; 12:177-84.
47. Li X, Lin HH, Chen H, Xu X, Shih HM, Ann DK. SUMOylation of the transcriptional co-repressor KAP1 is regulated by the serine and threonine phosphatase PP1. Sci Signal 2010; 3:32.
48. Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138-48.
49. Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 2001; 98:5134-9. (Pubitemid 32397095)
50. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90:425-35. (Pubitemid 27347233)
51. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 2009; 136:435-46.
52. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009; 136:420-34.
53. Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci USA 2009; 106:7155-60.
54. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21:3445-50. (Pubitemid 32381780)
55. 2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 2002; 30:285-9.
56. Hsu LC. Identification and functional characterization of a PP1-binding site in BRCA1. Biochem Biophys Res Commun 2007; 360:507-12.
57. Liu Y, Virshup DM, White RL, Hsu LC. Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha. Cancer Res 2002; 62:6357-61. (Pubitemid 35364085)
58. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer 2007; 7:85.
59. Yu YM, Pace SM, Allen SR, Deng CX, Hsu LC. A PP1-binding motif present in BRCA1 plays a role in its DNA repair function. Int J Biol Sci 2008; 4:352-61.
60. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 1993; 7:555-69. (Pubitemid 23125257)
61. Vietri M, Bianchi M, Ludlow JW, Mittnacht S, Villa- Moruzzi E. Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb. Cancer Cell Int 2006; 6:3.
62. Hirschi A, Cecchini M, Steinhardt RC, Schamber MR, Dick FA, Rubin SM. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol 2010; 17:1051-7.
63. Genovese C, Trani D, Caputi M, Claudio PP. Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene 2006; 25:5201-9. (Pubitemid 44299078)
64. Alberts AS, Thorburn AM, Shenolikar S, Mumby MC, Feramisco JR. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci USA 1993; 90:388-92. (Pubitemid 23028867)
65. Ludlow JW, Glendening CL, Livingston DM, DeCarprio JA. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 1993; 13:367-72. (Pubitemid 23006914)
66. Krucher NA, Rubin E, Tedesco VC, Roberts MH, Sherry TC, De LG. Dephosphorylation of Rb (Thr- 821) in response to cell stress. Exp Cell Res 2006; 312:2757-63.
67. Udho E, Tedesco VC, Zygmunt A, Krucher NA. PNUTS (phosphatase nuclear targeting subunit) inhibits retinoblastoma-directed PP1 activity. Biochem Biophys Res Commun 2002; 297:463-7.
68. De LG, Sherry TC, Krucher NA. Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis. Cancer Biol Ther 2008; 7:833-41.
69. Kim TH, Goodman J, Anderson KV, Niswander L. Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb- and E2F1-regulated cell cycle progression. Dev Cell 2007; 13:87-102.
70. Kampa KM, Bonin M, Lopez CD. New insights into the expanding complexity of the tumor suppressor ASPP2. Cell Cycle 2009; 8:2871-6.
71. Slee EA, Lu X. The ASPP family: deciding between life and death after DNA damage. Toxicol Lett 2003; 139:81-7. (Pubitemid 36298965)
72. Helps NR, Barker HM, Elledge SJ, Cohen PT. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett 1995; 377:295-300. (Pubitemid 26025716)
73. Liu CY, Lv X, Li T, Xu Y, Zhou X, Zhao S, et al. PP1 Cooperates with ASPP2 to dephosphorylate and activate TAZ. J Biol Chem 2010.
74. Cohen PT. Protein phosphatase 1 - targeted in many directions. J Cell Sci 2002; 115:241-56. (Pubitemid 34145174)
75. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, et al. A role for TAZ in migration, invasion and tumorigenesis of breast cancer cells. Cancer Res 2008; 68:2592-8. (Pubitemid 351556257)
76. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 2008; 28:2426-36. (Pubitemid 351429986)
77. Hollander MC, Zhan Q, Bae I, Fornace AJ Jr. Mammalian GADD34, an apoptosis- and DNA damage- inducible gene. J Biol Chem 1997; 272:13731-7. (Pubitemid 27224809)
78. Adler HT, Chinery R, Wu DY, Kussick SJ, Payne JM, Fornace AJ Jr, et al. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol 1999; 19:7050-60. (Pubitemid 29441887)
79. Grishin AV, Azhipa O, Semenov I, Corey SJ. Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis. Proc Natl Acad Sci USA 2001; 98:10172-7. (Pubitemid 32802993)
80. Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. JCell Biol 2001; 153:1011-22.
81. Shi W, Sun C, He B, Xiong W, Shi X, Yao D, et al. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol 2004; 164:291-300. (Pubitemid 38133948)
82. Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by downregulating its type-II receptor and inducing Smad7. J Biol Chem 2001; 276:26349-56.
83. Haneda M, Kojima E, Nishikimi A, Hasegawa T, Nakashima I, Isobe K. Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett 2004; 567:171-4. (Pubitemid 38748387)
84. Fletcher L, Cerniglia GJ, Nigg EA, Yend TJ, Muschel RJ. Inhibition of centrosome separation after DNA damage: a role for Nek2. Radiat Res 2004; 162:128-35. (Pubitemid 39100011)
85. Fry AM, Meraldi P, Nigg EA. A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. EMBO J 1998; 17:470-81. (Pubitemid 28045488)
86. Schultz SJ, Fry AM, Sutterlin C, Ried T, Nigg EA. Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans. Cell Growth Differ 1994; 5:625-35. (Pubitemid 24252327)
87. Helps NR, Luo X, Barker HM, Cohen PT. NIMA-related kinase 2 (Nek2), a cell cycle-regulated protein kinase localized to centrosomes, is complexed to protein phosphatase 1. Biochem J 2000; 349:509-18. (Pubitemid 30465786)
88. Meraldi P, Nigg EA. Centrosome cohesion is regulated by a balance of kinase and phosphatase activities. J Cell Sci 2001; 114:3749-57. (Pubitemid 33041056)
89. Mi J, Guo C, Brautigan DL, Larner JM. Protein phosphatase-1alpha regulates centrosome splitting through Nek2. Cancer Res 2007; 67:1082-9.
90. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2007; 7:495-507.
91. Millar JB, Blevitt J, Gerace L, Sadhu K, Featherstone C, Russell P. p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc Natl Acad Sci USA 1991; 88:10500-4. (Pubitemid 21915863)
92. Bulavin DV, Higashimoto Y, Demidenko ZN, Meek S, Graves P, Phillips C, et al. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol 2003; 5:545-51. (Pubitemid 36781089)
93. Dalal SN, Schweitzer CM, Gan J, Decaprio JA. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. MolCell Biol 1999; 19:4465-79. (Pubitemid 29242020)
94. Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998; 282:1893-7. (Pubitemid 28555269)
95. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277:1501-5. (Pubitemid 27449237)
96. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277:1497-501. (Pubitemid 27449236)
97. Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J 2003; 22:5734-45. (Pubitemid 37408813)
98. Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol 2001; 21:3853-61. (Pubitemid 32476448)
99. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68. (Pubitemid 28124064)
100. van AH, Gasser SM. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol 2009; 19:207-17.
101. Bazzi M, Mantiero D, Trovesi C, Lucchini G, Longhese MP. Dephosphorylation of gamma H2A by Glc7/protein phosphatase 1 promotes recovery from inhibition of DNA replication. Mol Cell Biol 2010; 30:131-45.
102. Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, et al. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell 2008; 31:33-46. (Pubitemid 351905923)
103. Keogh MC, Kim JA, Downey M, Fillingham J, Chowdhury D, Harrison JC, et al. A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature 2006; 439:497-501. (Pubitemid 43152843)
104. Nakada S, Chen GI, Gingras AC, Durocher D. PP4 is a gamma H2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep 2008; 9:1019-26.
105. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 2005; 20:801-9. (Pubitemid 41740701)
106. Cha H, Lowe JM, Li H, Lee JS, Belova GI, Bulavin DV, et al. Wip1 directly dephosphorylates gamma- H2AX and attenuates the DNA damage response. Cancer Res 2010; 70:4112-22.
107. Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene 2010; 29:2281-91.
108. Moon SH, Lin L, Zhang X, Nguyen TA, Darlington Y, Waldman AS, et al. Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma- H2AX and suppresses DNA double strand break repair. J Biol Chem 2010; 285:12935-47.
109. Shimada M, Niida H, Zineldeen DH, Tagami H, Tanaka M, Saito H, et al. Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell 2008; 132:221-32. (Pubitemid 351172429)
110. Shimada M, Haruta M, Niida H, Sawamoto K, Nakanishi M. Protein phosphatase 1gamma is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage. EMBO Rep 2010; 11:883-9.
111. Mendez-Acuna L, Di Tomaso MV, Palitti F, Martinez-Lopez W. Histone post-translational modifications in DNA damage response. Cytogenet Genome Res 2010; 128:28-36.
112. den EN, Kosoy A, Christopoulos H, O'Connell MJ. Resisting arrest: recovery from checkpoint arrest through dephosphorylation of Chk1 by PP1. Cell Cycle 2004; 3:529-33. (Pubitemid 40278178)
113. Guo C, Mi J, Brautigan DL, Larner JM. ATM regulates ionizing radiation-induced disruption of HDAC1:PP1:Rb complexes. Cell Signal 2007; 19:504-10. (Pubitemid 46107801)
114. Peng A, Maller JL. Serine/threonine phosphatases in the DNA damage response and cancer. Oncogene 2010; 29:5977-88.
115. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003; 4:231.